Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension-Reference-Cited by-同舟云学术

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension

Published:1998-10 Issue:10 Volume:105 Page:1960-1967
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

LeBlanc Raymond P

Publisher

Elsevier BV

Subject

Ophthalmology

Reference23 articles.

1. Systemic effects of medications used to treat glaucoma;Everitt;Ann Intern Med,1990

2. Systemic drug interactions with topical glaucoma medications;Gerber;Surv Ophthalmol,1990

3. Systemic adverse reactions to glaucoma medications;Fraunfelder;Int Ophthalmol Clin,1989

4. Topical β-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol;Lynch;Arch Ophthalmol,1988

5. Therapeutic use of α2-adrenoceptor agonists in glaucoma;Burke,1996

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients;Journal of Clinical Medicine;2024-07-16

2. Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-03-02

3. Pharmacotherapy of glaucoma in terms of evidence-based medicine;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-10-20

4. Brimonidine induced bilateral hypertensive anterior uveitis: Case report and review of the literature;Journal Français d'Ophtalmologie;2023-05

5. Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial;Scientific Reports;2023-04-07